reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Mirum Pharmaceuticals, Inc.

MIRM · Nasdaq

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$2.3Bpublic float
2024-02-28most recent failure

Score over time

012202220232024202520262024-04-01 · score 12024-02-28 filed late (10-K) · material weakness2024-07-01 · score 12024-02-28 filed late (10-K) · material weakness2024-10-01 · score 12024-02-28 filed late (10-K) · material weakness2025-01-01 · score 12024-02-28 filed late (10-K) · material weakness

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Mirum Pharmaceuticals, Inc. (the “Company”) is unable to timely file with the Securities and Exchange Commission (“SEC”) its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report”) without unreasonable effort or expense. This is the first year the Company is an accelerated filer, its filing deadlines are therefore shorter than they were in the past and it is the first year that the Company’s auditor has been required to attest to, and report on, management’s assessment of the Company’s internal control over financial reporting. The delay in the filing of the Annual Report is primarily due to a combination of factors relating to the testing and documentation of the Company’s internal controls associated with its use of and reliance upon third-party vendors and service providers. The Company anticipates that the Annual Report will be filed on or before the fifteenth calendar day following the prescribed due date

NT 10-K, filed 2024-02-28 · material weakness

What it filed

2024-02-28filed late (10-K)material weakness SEC →

Mirum Pharmaceuticals, Inc. (the “Company”) is unable to timely file with the Securities and Exchange Commission (“SEC”) its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report”) without unreasonable effort or expense. This is the first year the Company is an accelerated filer, its filing deadlines are therefore shorter than they were in the past and it is the first year that the Company’s auditor has been required to attest to, and report on, management’s assessment of the Company’s internal control over financial reporting. The delay in the filing of the Annual Report is primarily due to a combination of factors relating to the testing and documentation of the Company’s internal controls associated with its use of and reliance upon third-party vendors and service providers. The Company anticipates that the Annual Report will be filed on or before the fifteenth calendar day following the prescribed due date

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com